Clinical Trial Update: A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase I study evaluating daily-schedule oral taxane BMS-275183 in combination with esomeprazole in patients with advanced cancer. The trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-275183
• Esomeprazole (Esomeprazole)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cancer | Phase 1 | Status: TERMINATED